nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifapentine—CYP2C9—Estropipate—osteoporosis	0.0884	0.0902	CbGbCtD
Rifapentine—CYP2C8—Raloxifene—osteoporosis	0.0846	0.0862	CbGbCtD
Rifapentine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0817	0.0833	CbGbCtD
Rifapentine—CYP3A7—Estradiol—osteoporosis	0.073	0.0744	CbGbCtD
Rifapentine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.073	0.0744	CbGbCtD
Rifapentine—CYP2C8—Cholecalciferol—osteoporosis	0.0653	0.0666	CbGbCtD
Rifapentine—CYP3A5—Estradiol—osteoporosis	0.0548	0.0558	CbGbCtD
Rifapentine—CYP2C8—Estradiol—osteoporosis	0.0527	0.0537	CbGbCtD
Rifapentine—CYP3A4—Estropipate—osteoporosis	0.0514	0.0524	CbGbCtD
Rifapentine—CYP3A4—Calcitriol—osteoporosis	0.0514	0.0524	CbGbCtD
Rifapentine—CYP2C9—Cholecalciferol—osteoporosis	0.0456	0.0464	CbGbCtD
Rifapentine—CYP2D6—Cholecalciferol—osteoporosis	0.0417	0.0425	CbGbCtD
Rifapentine—CYP3A4—Ergocalciferol—osteoporosis	0.0411	0.0419	CbGbCtD
Rifapentine—CYP2C9—Estradiol—osteoporosis	0.0367	0.0374	CbGbCtD
Rifapentine—CYP3A4—Raloxifene—osteoporosis	0.0343	0.035	CbGbCtD
Rifapentine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0331	0.0338	CbGbCtD
Rifapentine—CYP3A4—Cholecalciferol—osteoporosis	0.0265	0.027	CbGbCtD
Rifapentine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0243	0.0248	CbGbCtD
Rifapentine—CYP3A4—Estradiol—osteoporosis	0.0214	0.0218	CbGbCtD
Rifapentine—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000127	0.00665	CbGpPWpGaD
Rifapentine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000125	0.00654	CbGpPWpGaD
Rifapentine—CYP3A43—Biological oxidations—POMC—osteoporosis	0.000114	0.00599	CbGpPWpGaD
Rifapentine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000114	0.00597	CbGpPWpGaD
Rifapentine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000112	0.00589	CbGpPWpGaD
Rifapentine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000111	0.00584	CbGpPWpGaD
Rifapentine—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00011	0.00576	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PKM—osteoporosis	0.000108	0.00565	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—FDPS—osteoporosis	0.000108	0.00565	CbGpPWpGaD
Rifapentine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000107	0.00562	CbGpPWpGaD
Rifapentine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000107	0.0056	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	0.000105	0.00553	CbGpPWpGaD
Rifapentine—CYP2C8—Arachidonic acid metabolism—GPX1—osteoporosis	0.000105	0.0055	CbGpPWpGaD
Rifapentine—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000104	0.00546	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	0.000104	0.00545	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PGLS—osteoporosis	0.000102	0.00536	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—GPD2—osteoporosis	0.000102	0.00536	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PNP—osteoporosis	9.35e-05	0.0049	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—ATIC—osteoporosis	9.35e-05	0.0049	CbGpPWpGaD
Rifapentine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	9.23e-05	0.00484	CbGpPWpGaD
Rifapentine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.15e-05	0.00479	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—CYP27A1—osteoporosis	9.13e-05	0.00479	CbGpPWpGaD
Rifapentine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.07e-05	0.00475	CbGpPWpGaD
Rifapentine—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.03e-05	0.00473	CbGpPWpGaD
Rifapentine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	9.03e-05	0.00473	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—CYP27A1—osteoporosis	9.01e-05	0.00472	CbGpPWpGaD
Rifapentine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.95e-05	0.00469	CbGpPWpGaD
Rifapentine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.67e-05	0.00454	CbGpPWpGaD
Rifapentine—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	8.54e-05	0.00448	CbGpPWpGaD
Rifapentine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	8.23e-05	0.00431	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CA2—osteoporosis	7.95e-05	0.00417	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—OXCT1—osteoporosis	7.95e-05	0.00417	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—MGLL—osteoporosis	7.75e-05	0.00406	CbGpPWpGaD
Rifapentine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.73e-05	0.00405	CbGpPWpGaD
Rifapentine—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	7.66e-05	0.00402	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	7.56e-05	0.00396	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	7.5e-05	0.00393	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	7.43e-05	0.00389	CbGpPWpGaD
Rifapentine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.41e-05	0.00389	CbGpPWpGaD
Rifapentine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	7.4e-05	0.00388	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	7.39e-05	0.00387	CbGpPWpGaD
Rifapentine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.35e-05	0.00385	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	7.33e-05	0.00384	CbGpPWpGaD
Rifapentine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.69e-05	0.00351	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—IDH2—osteoporosis	6.59e-05	0.00345	CbGpPWpGaD
Rifapentine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.27e-05	0.00328	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CYP27A1—osteoporosis	6.19e-05	0.00325	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.11e-05	0.0032	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—ACP5—osteoporosis	6.02e-05	0.00316	CbGpPWpGaD
Rifapentine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.98e-05	0.00313	CbGpPWpGaD
Rifapentine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.9e-05	0.00309	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.79e-05	0.00303	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—TPI1—osteoporosis	5.6e-05	0.00293	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	5.54e-05	0.0029	CbGpPWpGaD
Rifapentine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.5e-05	0.00288	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	5.46e-05	0.00286	CbGpPWpGaD
Rifapentine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.45e-05	0.00286	CbGpPWpGaD
Rifapentine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.43e-05	0.00284	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—P4HB—osteoporosis	5.27e-05	0.00276	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—GAPDH—osteoporosis	5.17e-05	0.00271	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—RAP1A—osteoporosis	5.03e-05	0.00264	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.97e-05	0.0026	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.9e-05	0.00257	CbGpPWpGaD
Rifapentine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.85e-05	0.00254	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.83e-05	0.00253	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	4.8e-05	0.00251	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	4.73e-05	0.00248	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.71e-05	0.00247	CbGpPWpGaD
Rifapentine—CYP3A7—Biological oxidations—POMC—osteoporosis	4.6e-05	0.00241	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.5e-05	0.00236	CbGpPWpGaD
Rifapentine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.46e-05	0.00233	CbGpPWpGaD
Rifapentine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.42e-05	0.00231	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.39e-05	0.0023	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PKM—osteoporosis	4.34e-05	0.00228	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—FDPS—osteoporosis	4.34e-05	0.00228	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PGLS—osteoporosis	4.12e-05	0.00216	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—GPD2—osteoporosis	4.12e-05	0.00216	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—ENO1—osteoporosis	4.07e-05	0.00213	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PSMA5—osteoporosis	4.01e-05	0.0021	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PSMA2—osteoporosis	4.01e-05	0.0021	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	3.94e-05	0.00206	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	3.9e-05	0.00205	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	3.88e-05	0.00204	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	3.85e-05	0.00202	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—ATIC—osteoporosis	3.77e-05	0.00197	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PNP—osteoporosis	3.77e-05	0.00197	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.66e-05	0.00192	CbGpPWpGaD
Rifapentine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.59e-05	0.00188	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.57e-05	0.00187	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.51e-05	0.00184	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—POMC—osteoporosis	3.33e-05	0.00174	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CYP19A1—osteoporosis	3.25e-05	0.0017	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CA2—osteoporosis	3.2e-05	0.00168	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—OXCT1—osteoporosis	3.2e-05	0.00168	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—FDPS—osteoporosis	3.14e-05	0.00165	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PKM—osteoporosis	3.14e-05	0.00165	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—MGLL—osteoporosis	3.12e-05	0.00164	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.98e-05	0.00156	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PGLS—osteoporosis	2.98e-05	0.00156	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—GPD2—osteoporosis	2.98e-05	0.00156	CbGpPWpGaD
Rifapentine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.91e-05	0.00153	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—POMC—osteoporosis	2.88e-05	0.00151	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.85e-05	0.0015	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PNP—osteoporosis	2.72e-05	0.00143	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—ATIC—osteoporosis	2.72e-05	0.00143	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—FDPS—osteoporosis	2.72e-05	0.00142	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PKM—osteoporosis	2.72e-05	0.00142	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—ADCY5—osteoporosis	2.66e-05	0.00139	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—IDH2—osteoporosis	2.65e-05	0.00139	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—GPX1—osteoporosis	2.65e-05	0.00139	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PGLS—osteoporosis	2.58e-05	0.00135	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—GPD2—osteoporosis	2.58e-05	0.00135	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.57e-05	0.00135	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.54e-05	0.00133	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CYP27A1—osteoporosis	2.49e-05	0.00131	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—MTHFR—osteoporosis	2.44e-05	0.00128	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.43e-05	0.00127	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—ACP5—osteoporosis	2.43e-05	0.00127	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—POMC—osteoporosis	2.37e-05	0.00124	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PNP—osteoporosis	2.36e-05	0.00124	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—ATIC—osteoporosis	2.36e-05	0.00124	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—POMC—osteoporosis	2.35e-05	0.00123	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—OXCT1—osteoporosis	2.31e-05	0.00121	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CA2—osteoporosis	2.31e-05	0.00121	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—TPI1—osteoporosis	2.26e-05	0.00118	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—MGLL—osteoporosis	2.26e-05	0.00118	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—FDPS—osteoporosis	2.23e-05	0.00117	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PKM—osteoporosis	2.23e-05	0.00117	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PKM—osteoporosis	2.21e-05	0.00116	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—FDPS—osteoporosis	2.21e-05	0.00116	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—P4HB—osteoporosis	2.12e-05	0.00111	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—GPD2—osteoporosis	2.12e-05	0.00111	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PGLS—osteoporosis	2.12e-05	0.00111	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—GPD2—osteoporosis	2.1e-05	0.0011	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PGLS—osteoporosis	2.1e-05	0.0011	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—GAPDH—osteoporosis	2.08e-05	0.00109	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—RAP1A—osteoporosis	2.03e-05	0.00106	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CA2—osteoporosis	2e-05	0.00105	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—OXCT1—osteoporosis	2e-05	0.00105	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—POMC—osteoporosis	1.96e-05	0.00102	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—MGLL—osteoporosis	1.95e-05	0.00102	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—ATIC—osteoporosis	1.94e-05	0.00101	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PNP—osteoporosis	1.94e-05	0.00101	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PNP—osteoporosis	1.92e-05	0.00101	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—ATIC—osteoporosis	1.92e-05	0.00101	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—IDH2—osteoporosis	1.92e-05	0.001	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.84e-05	0.000965	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.8e-05	0.000945	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—ACP5—osteoporosis	1.75e-05	0.000919	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—IDH2—osteoporosis	1.66e-05	0.00087	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.65e-05	0.000862	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CA2—osteoporosis	1.65e-05	0.000862	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—ENO1—osteoporosis	1.64e-05	0.000859	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CA2—osteoporosis	1.63e-05	0.000855	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—OXCT1—osteoporosis	1.63e-05	0.000855	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—TPI1—osteoporosis	1.63e-05	0.000855	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PSMA2—osteoporosis	1.62e-05	0.000846	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PSMA5—osteoporosis	1.62e-05	0.000846	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—MGLL—osteoporosis	1.6e-05	0.00084	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—MGLL—osteoporosis	1.59e-05	0.000833	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.56e-05	0.000818	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.55e-05	0.000811	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—P4HB—osteoporosis	1.53e-05	0.000803	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—ACP5—osteoporosis	1.52e-05	0.000796	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—GAPDH—osteoporosis	1.5e-05	0.000789	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.5e-05	0.000786	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.5e-05	0.000786	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—RAP1A—osteoporosis	1.47e-05	0.000768	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—FDPS—osteoporosis	1.46e-05	0.000765	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PKM—osteoporosis	1.46e-05	0.000765	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—TPI1—osteoporosis	1.41e-05	0.00074	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—GPD2—osteoporosis	1.38e-05	0.000725	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PGLS—osteoporosis	1.38e-05	0.000725	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—IDH2—osteoporosis	1.36e-05	0.000715	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—IDH2—osteoporosis	1.35e-05	0.000708	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—P4HB—osteoporosis	1.33e-05	0.000696	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.31e-05	0.000687	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—GAPDH—osteoporosis	1.3e-05	0.000683	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.28e-05	0.000672	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.27e-05	0.000666	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—RAP1A—osteoporosis	1.27e-05	0.000665	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PNP—osteoporosis	1.27e-05	0.000663	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—ATIC—osteoporosis	1.27e-05	0.000663	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—ACP5—osteoporosis	1.25e-05	0.000654	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—ACP5—osteoporosis	1.24e-05	0.000648	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.22e-05	0.00064	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—ENO1—osteoporosis	1.18e-05	0.000621	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PSMA2—osteoporosis	1.17e-05	0.000612	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PSMA5—osteoporosis	1.17e-05	0.000612	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—TPI1—osteoporosis	1.16e-05	0.000608	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—TPI1—osteoporosis	1.15e-05	0.000602	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.11e-05	0.00058	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—P4HB—osteoporosis	1.09e-05	0.000571	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—P4HB—osteoporosis	1.08e-05	0.000566	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.08e-05	0.000564	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CA2—osteoporosis	1.08e-05	0.000564	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—ADCY5—osteoporosis	1.07e-05	0.000561	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.07e-05	0.000561	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—GPX1—osteoporosis	1.07e-05	0.000559	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.06e-05	0.000556	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—MGLL—osteoporosis	1.05e-05	0.000549	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.04e-05	0.000546	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.03e-05	0.000541	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—ENO1—osteoporosis	1.03e-05	0.000538	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PSMA2—osteoporosis	1.01e-05	0.00053	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PSMA5—osteoporosis	1.01e-05	0.00053	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—MTHFR—osteoporosis	9.85e-06	0.000516	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CYP19A1—osteoporosis	9.47e-06	0.000496	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.01e-06	0.000472	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—IDH2—osteoporosis	8.92e-06	0.000467	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—ENO1—osteoporosis	8.42e-06	0.000441	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.38e-06	0.000439	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—ENO1—osteoporosis	8.35e-06	0.000438	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PSMA5—osteoporosis	8.3e-06	0.000435	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PSMA2—osteoporosis	8.3e-06	0.000435	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PSMA2—osteoporosis	8.23e-06	0.000431	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PSMA5—osteoporosis	8.23e-06	0.000431	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CYP19A1—osteoporosis	8.2e-06	0.00043	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—ACP5—osteoporosis	8.15e-06	0.000427	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—POMC—osteoporosis	7.87e-06	0.000413	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—ADCY5—osteoporosis	7.74e-06	0.000406	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—GPX1—osteoporosis	7.71e-06	0.000404	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—TPI1—osteoporosis	7.58e-06	0.000397	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—P4HB—osteoporosis	7.13e-06	0.000374	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—MTHFR—osteoporosis	7.12e-06	0.000373	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—GAPDH—osteoporosis	7e-06	0.000367	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—RAP1A—osteoporosis	6.81e-06	0.000357	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CYP19A1—osteoporosis	6.74e-06	0.000353	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—ADCY5—osteoporosis	6.7e-06	0.000351	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—GPX1—osteoporosis	6.68e-06	0.00035	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CYP19A1—osteoporosis	6.68e-06	0.00035	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—MTHFR—osteoporosis	6.16e-06	0.000323	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—POMC—osteoporosis	5.69e-06	0.000298	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—ENO1—osteoporosis	5.51e-06	0.000289	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—ADCY5—osteoporosis	5.5e-06	0.000288	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—GPX1—osteoporosis	5.48e-06	0.000287	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—ADCY5—osteoporosis	5.46e-06	0.000286	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—GPX1—osteoporosis	5.44e-06	0.000285	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PSMA2—osteoporosis	5.43e-06	0.000284	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PSMA5—osteoporosis	5.43e-06	0.000284	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—MTHFR—osteoporosis	5.06e-06	0.000265	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—MTHFR—osteoporosis	5.02e-06	0.000263	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—POMC—osteoporosis	4.93e-06	0.000258	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.4e-06	0.000231	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—POMC—osteoporosis	4.05e-06	0.000212	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—POMC—osteoporosis	4.01e-06	0.00021	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.6e-06	0.000189	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—GPX1—osteoporosis	3.59e-06	0.000188	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.31e-06	0.000173	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—POMC—osteoporosis	2.65e-06	0.000139	CbGpPWpGaD
